Información del artículo
El Texto completo está disponible en PDF
Bibliografía seleccionada
[Abraham et al., 2002]
W. Abraham, et al.
Cardiac Resynchronization in Chronic Heart Failure.
The New England Journal of Medicine, 346 (2002), pp. 1844-1853
[Bradley et al., 2003]
D. Bradley, et al.
Cardiac Resynchronization and Death from Progressive Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
JAMA, 289 (2003), pp. 730-740
[Bristow et al., 2420]
Bristow, M., et al.,Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) Investigators: Cardiac Resynchronization Therapy (CRT) Reduces Hospitalizations, and CRT with Implantable Defibrillator (CRT-D) Reduces Mortality in Chronic Heart Failure: The COMPANION Trial.Presented at the Heart Failure Society meeting, September 242003. Las Vegas, Nev.
[Hunt et al., 2001]
S. Hunt, et al.
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).
Journal of the American College of Cardiology, 38 (2001), pp. 2101-2113
[Jessup and Brozena, 2003]
M. Jessup, S. Brozena.
Heart Failure.
The New England Journal of Medicine, 348 (2003), pp. 2007-2017
[Maisel et al., 2002]
A. Maisel, et al.
Rapid Measurement of B-type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure.
The New England Journal of Medicine., 347 (2002), pp. 161-167
[Poole-Wilson et al., 2003]
P. Poole-Wilson, et al.
Comparison of Carvedilol and Metoprolol on Clinical Outcomes in Patients with Chronic Heart Failure in the Carvedilol or Metoprolol European Trial (COMET): Randomized Controlled Trial.
Lancet, 362 (2003), pp. 7-13
Copyright © 2005. Lippincott Williams & Wilkins